Cold Sore Treatment and Management

Introduction to Cold Sores

Herpes labialis (cold sores or fever blisters) is primarily caused by HSV-1 and affects 20-40% of the adult population 2
The virus establishes latency in sensory ganglia and reactivates due to triggers like ultraviolet light exposure, fever, psychological stress, and menstruation 2
Cold sores progress through stages: prodrome (itching, burning), erythema, papule formation, vesicle, pustulation, ulceration, and scabbing 2
Peak viral titers occur in the first 24 hours after lesion onset, making early treatment crucial 2

Valacyclovir 2g twice daily for 1 day is the recommended first-line treatment, reducing median episode duration by 1.0 day compared to placebo 1
Treatment should be initiated within 24 hours of symptom onset, ideally during the prodromal stage for maximum effectiveness 1, 2
Famciclovir 1500mg as a single dose is an effective alternative, significantly reducing time to healing of primary lesions 1
Acyclovir 400mg five times daily for 5 days is another option but requires more frequent dosing 1

Topical antivirals provide only modest clinical benefit and are less effective than oral therapy 1, 3
Apply white soft paraffin ointment to the lips every 2 hours throughout the acute illness 4
Topical anesthetics (e.g., benzydamine hydrochloride) can help manage pain 4, 3
Antiseptic oral rinses (e.g., 1.5% hydrogen peroxide or 0.2% chlorhexidine digluconate) can reduce bacterial colonization 4

Consider suppressive therapy if experiencing six or more recurrences per year 2, 1
First-line suppressive therapy options include valacyclovir 500mg once daily, which can increase to 1000mg once daily for very frequent recurrences 1
Daily suppressive therapy can reduce the frequency of herpes recurrences by ≥75% 1
Topical antivirals are not effective for suppressive therapy 3, 1

For immunocompromised patients, higher doses or longer treatment durations may be required 1
Oral antiviral medications are generally well-tolerated with minimal adverse events, with common side effects including headache, nausea, and mild gastrointestinal disturbances 2, 1
The development of resistance to oral antiviral agents when used episodically in immunocompetent patients is rare (<0.5%) 1

Relying solely on topical treatments when oral therapy is more effective 1
Starting treatment too late, as efficacy decreases significantly when treatment is initiated after lesions have fully developed 1
Using topical antivirals for suppressive therapy, which is ineffective since they cannot reach the site of viral reactivation 3, 1
Failing to consider suppressive therapy in patients with frequent recurrences who could significantly benefit 1

Identify and avoid personal triggers (stress, fever, sunlight) 2
Use sunscreen or zinc oxide to decrease the probability of recurrent outbreaks 3